JPMorgan upgrades GoDaddy to Overweight with $110 price target
JPMorgan analyst Sterling Auty upgraded GoDaddy to Overweight from Neutral with a price target of $110, up from $83, following last night's Q2 results. The...
Author : The Fly
Moderna COVID vaccine still has ‘best-in-class potential,’ says Barclays
Barclays analyst Gena Wang raised the firm's price target on Moderna (MRNA) to $84 from $68 and keeps an Overweight rating on the shares. The...
Novavax price target raised to $290 from $132 at H.C. Wainwright
H.C. Wainwright analyst Vernon Bernardino raised the firm's price target on Novavax to $290 from $132 and keeps a Buy rating on the shares. The...
Notable companies reporting before tomorrow’s open
Notable companies reporting before tomorrow's open, with earnings consensus, include Bristol-Myers Squibb (BMY), consensus $1.48... Becton Dickinson (BDX), consensus $2.04... Zoetis (ZTS), consensus 64c... Ball...
Notable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Fiserv (FISV), consensus 93c... MetLife (MET), consensus 90c... Carvana (CVNA), consensus (83c)... Roku (ROKU),...
Energy shares surge amid spike in natural gas, crude inventory drop
This past week saw a noticeable outperformance of energy-related shares as measured by the Energy Select Sector SPDR Fund (XLE) compared to the S&P 500....
Disney jumps after reporting quarterly results, 100M streaming subscribers
Shares of Disney (DIS) are on the rise on Wednesday after the company reported mixed third quarter results, announced a new entertainment streaming service in...
Fulgent Genetics surges after ‘record’ Q2 results
Shares of Fulgent Genetics (FLGT) have surged during the session after the company reported second quarter results after the market close last night. The company...
#SocialStocks: Microsoft in talks to buy TikTok, Instagram launches Reels
Welcome to "#SocialStocks," The Fly's weekly recap of Wall Street's reactions to social media stock news. TIKTOK ACQUISITION TALKS:... To see the rest of the...
Street Fight: JPMorgan says buy Novavax, Ladenburg says sell after vaccine data
Shares of Novavax (NVAX) are on the rise on Wednesday after the company announced data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of its...